SCHEMBL16375263

SCHEMBL16375263

Cc1c(C(C)C)c2c(C(C)C)ncnn2c1C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24392173 0.71 ALDH1A1 (0.31) —
SCHEMBL16375262 0.70 — —
SCHEMBL24391766 0.69 ALDH1A1 (0.41) —
SCHEMBL13968294 0.67 ALDH1A1 (0.31) —
SCHEMBL24392633 0.67 SMN1; SMN2 (0.31) —
SCHEMBL24391694 0.67 KDR (0.31) —
SCHEMBL24391780 0.67 ACVRL1 (0.33) —
SCHEMBL24391697 0.67 ALDH1A1 (0.33) —
SCHEMBL24391796 0.64 EGLN2 (0.35) —
SCHEMBL24391770 0.63 RET (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9458162-B2 Cyclic molecules as bruton's tyrosine kinase inhibitors NANJING ALLGEN PHARMA CO. LTD. (CN) 2016-10-04 — — US disclosed
US-20150011530-A1 CYCLIC MOLECULES AS BRUTON'S TYROSINE KINASE INHIBITORS GUANGDONG NEWOPP BIOPHARMACEUTICALS CO., LTD. (CN) 2015-01-08 — — US disclosed
Send feedback